CP 154526Alternative Names: antalarmin
Latest Information Update: 20 Jun 2002
At a glance
- Originator Pfizer
- Developer Eisai Co Ltd; Pfizer
- Class Antidepressants
- Mechanism of Action Corticotropin-releasing factor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Anxiety disorders; Major depressive disorder